Dr. Roger Stupp, MD
Chair
Dr. Roger Stupp is Chief of Neuro-Oncology in the Department of Neurology and Neurological Surgery at Northwestern University Feinberg School of Medicine and Co-Director of the Northwestern Medicine Lou and Jean Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital in Chicago, Illinois. As Associate Director of Strategic Initiatives, he is instrumental in the development and oversight of Lurie Cancer Center’s strategic scientific initiatives applying advanced technologies and collaborative approaches to accelerate and widen the scope of clinical research. Dr. Stupp’s clinical interests include the multimodality management of primary and secondary brain tumors, head and neck tumors, and lung cancers, as well as new drug development and the association of chemotherapy and radiation therapy. Dr. Stupp’s work has repeatedly led to the establishment of a new standard of care for newly diagnosed glioblastoma, namely he was instrumental in developing and establishing the combination of temozolomide and radiotherapy, and more recently, for the clinical development of Tumor Treating Fields in brain tumors.
Dr. Isabelle M. Germano
Dr. Isabelle M. Germano is a distinguished neurosurgeon and professor at the Icahn School of Medicine at Mount Sinai Hospital. She graduated from the University of Turin Medical School in 1984, subsequently completing her neurology residency and neurosurgery residency at institutions including the University of California San Francisco and the Albert Einstein College of Medicine. Throughout her career, Germano has been a pioneer in brain tumor and stereotactic clinical programs, specializing in image-guided brain and spine surgery. She has developed innovative technologies and techniques, and her expertise extends to teaching and training neurosurgeons worldwide. Germano's research interests encompass brain tumor translational research, focusing on gene therapy and stem cells. Her outstanding contributions have earned her recognition, including the Leksell Radiosurgery Award, and she is the author of numerous publications, solidifying her reputation as a leader in the field of neurosurgery.
Dr. Michael Lim
Dr. Michael Lim is the Chairman of the Department of Neurosurgery at Stanford University, Stanford California. He is a board-certified neurosurgeon specializing in brain tumors and trigeminal neuralgia. Dr. Michael Lim is a global leader in cancer immunotherapy with a strong focus on neurological tumors. Dr. Lim has extensive clinical experience in treating brain tumors by deploying the most advanced surgical techniques. In addition to running a successful laboratory, Dr. Lim has experience in developing novel therapies and advancing these pharmaceuticals into the clinic. Dr. Lim has published more than 200 scientific articles on neuropathic pain, glioblastoma multiforme, and gliomas. Such publications have appeared in high-profile journals such as Science Translational Medicine, Clinical Cancer Research, Lancet Oncology, and Nature Immunology.
